Arnoud W J van 't Hof Selected Research

Stroke (Strokes)

11/2023	Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
11/2023	Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention.
8/2023	Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry.
11/2022	Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.
1/2022	Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
10/2019	A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
7/2014	CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.
3/2012	Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arnoud W J van 't Hof Research Topics

Disease

66	ST Elevation Myocardial Infarction 11/2023 - 06/2002
43	Myocardial Infarction 11/2023 - 06/2002
28	Infarction (Infarctions) 01/2023 - 06/2002
23	Thrombosis (Thrombus) 11/2023 - 05/2004
16	Hemorrhage 11/2023 - 04/2010
15	Acute Coronary Syndrome 11/2023 - 08/2003
8	Stroke (Strokes) 11/2023 - 03/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 12/2007
5	Non-ST Elevated Myocardial Infarction 08/2023 - 12/2007
5	Diabetes Mellitus 01/2021 - 06/2005
4	Atrial Fibrillation 11/2023 - 05/2013
3	Chest Pain (Chest Pains) 01/2022 - 01/2015
3	Ischemia 01/2021 - 04/2010
3	Necrosis 01/2017 - 06/2006
3	Heart Failure 11/2011 - 12/2005
2	Thrombocytopenia (Thrombopenia) 12/2023 - 04/2010
2	Pain (Aches) 01/2022 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 11/2006
2	Hyperglycemia 08/2011 - 04/2005
2	Pathologic Constriction (Stenosis) 04/2007 - 08/2006
1	Vomiting 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2021
1	Atrioventricular Block 06/2016
1	Neointima 01/2016
1	Death (Near-Death Experience) 03/2015
1	Out-of-Hospital Cardiac Arrest 02/2015
1	Ventricular Fibrillation 02/2015

Drug/Important Bio-Agent (IBA)

19	Tirofiban (Aggrastat)FDA Link 12/2023 - 05/2004
14	Glycoproteins (Glycoprotein)IBA 12/2023 - 08/2003
12	Clopidogrel (Plavix)FDA Link 01/2022 - 06/2004
10	omega-Chloroacetophenone (Mace)IBA 11/2023 - 04/2003
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 06/2002
9	TicagrelorIBA 03/2022 - 07/2014
8	Heparin (Liquaemin)FDA LinkGeneric 12/2023 - 06/2002
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2007
6	Insulin (Novolin)FDA Link 01/2021 - 09/2003
6	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 09/2003
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 09/2004
5	Cytochrome P-450 CYP2C19IBA 03/2022 - 12/2010
5	Prasugrel Hydrochloride FDA Link 03/2022 - 07/2014
5	TroponinIBA 01/2022 - 08/2007
4	Troponin T (Troponin T1)IBA 01/2022 - 07/2006
4	Creatine Kinase (Creatine Phosphokinase)IBA 07/2014 - 09/2008
4	PotassiumIBA 06/2005 - 09/2003
3	Abciximab (ReoPro)FDA Link 12/2023 - 08/2006
3	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2015
3	Sirolimus (Rapamycin)FDA Link 01/2016 - 01/2009
2	Troponin IIBA 01/2022 - 09/2008
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2015
2	Platelet Membrane Glycoprotein IIbIBA 07/2012 - 12/2007
2	C-Reactive ProteinIBA 02/2008 - 03/2004
1	Immunoglobulin G (IgG)IBA 12/2023
1	AntibodiesIBA 12/2023
1	Eptifibatide (Integrilin)FDA Link 12/2023
1	IntegrinsIBA 12/2023
1	SteroidsIBA 12/2023
1	AnticoagulantsIBA 11/2023
1	Thrombin FDA Link 11/2023
1	selatogrelIBA 11/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2022
1	Purinergic P2Y Receptor AntagonistsIBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	TabletsIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2019
1	Metoprolol (Toprol-XL)FDA LinkGeneric 06/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Everolimus FDA Link 03/2015
1	Growth Differentiation Factor 15IBA 01/2015
1	MyoglobinIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2015
1	Radioisotopes (Radionuclides)IBA 05/2013
1	Therapeutic UsesIBA 10/2011
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2011
1	Hemoglobin AIBA 08/2011
1	Cytochrome P-450 CYP2C9IBA 12/2010
1	CreatinineIBA 12/2010
1	Phosphotransferases (Kinase)IBA 12/2010
1	Platelet Membrane GlycoproteinsIBA 01/2009
1	MetalsIBA 01/2009

Therapy/Procedure

50	Percutaneous Coronary Intervention 01/2023 - 03/2004
33	Therapeutics 12/2023 - 06/2002
22	Stents 11/2022 - 06/2004
5	Transcatheter Aortic Valve Replacement 11/2023 - 10/2020
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 03/2012
4	Time-to-Treatment 02/2011 - 06/2004
4	Thrombolytic Therapy 12/2010 - 06/2002
2	Subcutaneous Injections 01/2023 - 08/2021
2	Punctures 10/2020 - 01/2020
2	Drug-Eluting Stents 01/2016 - 01/2009
1	Platelet Transfusion (Blood Platelet Transfusions) 12/2023
1	Embolic Protection Devices 11/2023
1	Injections 11/2023
1	Conservative Treatment 08/2023
1	Intravenous Administration 01/2021
1	Drug Prescriptions 01/2018
1	Length of Stay 11/2011
1	Secondary Prevention 03/2011